 |
인쇄하기
취소
|
GMP upgrade to reflect in NHI drug price determination as an incentive.
In discussion with the MOHW, the KFDA may implement new incentive plans for the products manufactured at the upgraded GMP (c-GMP) companies to reflect better NHI drug price approval.
The KFDA's incentive plan also included an exemption of regular pharmaceutical supervision against the outstanding rated GMP companies.
Such incentive plans came out after the National Assembly interpellatio...
The KFDA's incentive plan also included an exemption of regular pharmaceutical supervision against the outstanding rated GMP companies.
Such incentive plans came out after the National Assembly interpellatio...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.